Do analysts recommend BNR or AUNA?

Auna has a consensus target price of $6.97, indicating a potential upside of 35.28%. Given Auna's stronger consensus rating and higher probable upside, analysts clearly believe Auna is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Auna 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Does the media prefer BNR or AUNA?

In the previous week, Auna had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for Auna and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.94 beat Auna's score of 0.34 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Auna 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BNR or AIRS?

AirSculpt Technologies has a consensus price target of $4.50, suggesting a potential upside of 7.14%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts clearly believe AirSculpt Technologies is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AirSculpt Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend BNR or SBC?

SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 174.19%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SBC Medical Group 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor BNR or SBC?

In the previous week, SBC Medical Group had 2 more articles in the media than Burning Rock Biotech. MarketBeat recorded 4 mentions for SBC Medical Group and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.94 beat SBC Medical Group's score of 0.76 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SBC Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BNR or LFMD?

LifeMD has a consensus price target of $9.14, indicating a potential upside of 102.05%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70

Does the media refer more to BNR or LFMD?

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 2 articles in the media. LifeMD's average media sentiment score of 1.21 beat Burning Rock Biotech's score of 0.94 indicating that LifeMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate BNR or BDSX?

Biodesix has a consensus target price of $28.33, indicating a potential upside of 32.40%. Given Biodesix's stronger consensus rating and higher probable upside, analysts clearly believe Biodesix is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biodesix 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.80

Does the media prefer BNR or BDSX?

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 2 articles in the media. Biodesix's average media sentiment score of 1.83 beat Burning Rock Biotech's score of 0.94 indicating that Biodesix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biodesix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Burning Rock Biotech (BNR) Competitors

$9.90 -0.76 (-7.10%)

As of 12:34 PM Eastern

Compare

BNR vs. AUNA, AIRS, SBC, LFMD, and BDSX

Should you buy Burning Rock Biotech stock or one of its competitors? MarketBeat compares Burning Rock Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Burning Rock Biotech include Auna (AUNA), AirSculpt Technologies (AIRS), SBC Medical Group (SBC), LifeMD (LFMD), and Biodesix (BDSX). These companies are all part of the "healthcare" industry.

How does Burning Rock Biotech compare to Auna?

Burning Rock Biotech (NASDAQ:BNR) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

Auna has a consensus target price of $6.97, indicating a potential upside of 35.28%. Given Auna's stronger consensus rating and higher probable upside, analysts clearly believe Auna is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Auna has a net margin of 1.53% compared to Burning Rock Biotech's net margin of -11.57%. Auna's return on equity of 16.25% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
Auna	1.53%	16.25%	4.03%

In the previous week, Auna had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for Auna and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.94 beat Auna's score of 0.34 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Auna	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Auna has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.37	-$7.92M	-$0.82	N/A
Auna	$1.23B	0.31	$27.39M	$0.26	19.81

30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Burning Rock Biotech has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market. Comparatively, Auna has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Summary

Auna beats Burning Rock Biotech on 12 of the 17 factors compared between the two stocks.

How does Burning Rock Biotech compare to AirSculpt Technologies?

Burning Rock Biotech (NASDAQ:BNR) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Comparatively, 44.6% of AirSculpt Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Burning Rock Biotech has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.34, indicating that its share price is 134% more volatile than the broader market.

Burning Rock Biotech has higher earnings, but lower revenue than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.37	-$7.92M	-$0.82	N/A
AirSculpt Technologies	$151.82M	1.95	-$11.67M	-$0.17	N/A

AirSculpt Technologies has a net margin of -7.39% compared to Burning Rock Biotech's net margin of -11.57%. AirSculpt Technologies' return on equity of -4.98% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
AirSculpt Technologies	-7.39%	-4.98%	-2.36%

In the previous week, Burning Rock Biotech had 1 more articles in the media than AirSculpt Technologies. MarketBeat recorded 2 mentions for Burning Rock Biotech and 1 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 1.87 beat Burning Rock Biotech's score of 0.94 indicating that AirSculpt Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Burning Rock Biotech	Positive
AirSculpt Technologies	Very Positive

AirSculpt Technologies has a consensus price target of $4.50, suggesting a potential upside of 7.14%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts clearly believe AirSculpt Technologies is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

AirSculpt Technologies beats Burning Rock Biotech on 12 of the 15 factors compared between the two stocks.

How does Burning Rock Biotech compare to SBC Medical Group?

Burning Rock Biotech (NASDAQ:BNR) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

SBC Medical Group has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.37	-$7.92M	-$0.82	N/A
SBC Medical Group	$173.61M	1.83	$50.99M	$0.39	7.95

SBC Medical Group has a net margin of 24.09% compared to Burning Rock Biotech's net margin of -11.57%. SBC Medical Group's return on equity of 15.90% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
SBC Medical Group	24.09%	15.90%	11.61%

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 174.19%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Burning Rock Biotech has a beta of 1.32, meaning that its share price is 32% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

In the previous week, SBC Medical Group had 2 more articles in the media than Burning Rock Biotech. MarketBeat recorded 4 mentions for SBC Medical Group and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.94 beat SBC Medical Group's score of 0.76 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SBC Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

SBC Medical Group beats Burning Rock Biotech on 14 of the 16 factors compared between the two stocks.

How does Burning Rock Biotech compare to LifeMD?

Burning Rock Biotech (NASDAQ:BNR) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

LifeMD has a net margin of 2.37% compared to Burning Rock Biotech's net margin of -11.57%. Burning Rock Biotech's return on equity of -10.98% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
LifeMD	2.37%	-150.88%	-22.59%

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Comparatively, 17.2% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

LifeMD has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.37	-$7.92M	-$0.82	N/A
LifeMD	$194.05M	1.13	$14.35M	$0.05	90.50

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 2 articles in the media. LifeMD's average media sentiment score of 1.21 beat Burning Rock Biotech's score of 0.94 indicating that LifeMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeMD	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeMD has a consensus price target of $9.14, indicating a potential upside of 102.05%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Burning Rock Biotech has a beta of 1.32, meaning that its share price is 32% more volatile than the broader market. Comparatively, LifeMD has a beta of 1.99, meaning that its share price is 99% more volatile than the broader market.

Summary

LifeMD beats Burning Rock Biotech on 11 of the 15 factors compared between the two stocks.

How does Burning Rock Biotech compare to Biodesix?

Burning Rock Biotech (NASDAQ:BNR) and Biodesix (NASDAQ:BDSX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 2 articles in the media. Biodesix's average media sentiment score of 1.83 beat Burning Rock Biotech's score of 0.94 indicating that Biodesix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Biodesix	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 23.2% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Biodesix has a consensus target price of $28.33, indicating a potential upside of 32.40%. Given Biodesix's stronger consensus rating and higher probable upside, analysts clearly believe Biodesix is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80

Burning Rock Biotech has a net margin of -11.57% compared to Biodesix's net margin of -33.26%. Burning Rock Biotech's return on equity of -10.98% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
Biodesix	-33.26%	-2,101.40%	-35.65%

Burning Rock Biotech has higher earnings, but lower revenue than Biodesix. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.37	-$7.92M	-$0.82	N/A
Biodesix	$88.50M	2.51	-$35.26M	-$4.06	N/A

Burning Rock Biotech has a beta of 1.32, meaning that its stock price is 32% more volatile than the broader market. Comparatively, Biodesix has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market.

Summary

Burning Rock Biotech and Biodesix tied by winning 8 of the 16 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNR vs. The Competition

Export

Metric	Burning Rock Biotech	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$105.62M	$3.97B	$6.89B	$12.52B
Dividend Yield	N/A	2.12%	3.10%	8.00%
P/E Ratio	-12.24	35.54	28.84	24.40
Price / Sales	1.37	44.55	348.32	118.35
Price / Cash	N/A	36.88	23.21	49.36
Price / Book	1.38	4.17	5.70	6.34
Net Income	-$7.92M	$31.58M	$204.95M	$330.77M
7 Day Performance	-6.52%	-2.07%	-1.92%	-0.83%
1 Month Performance	16.88%	-6.73%	-2.53%	-0.25%
1 Year Performance	116.85%	2.67%	13.70%	20.22%

Burning Rock Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNR Burning Rock Biotech	1.138 of 5 stars	$9.90 -7.1%	N/A	+153.5%	$104.18M	$77.16M	N/A	1,390	Gap Down
AUNA Auna	4.9125 of 5 stars	$5.19 -2.2%	$6.97 +34.4%	-17.1%	$392.27M	$1.23B	19.94	15,254
AIRS AirSculpt Technologies	1.6298 of 5 stars	$4.22 -5.8%	$4.50 +6.6%	-15.7%	$316.05M	$151.82M	N/A	240
SBC SBC Medical Group	3.8007 of 5 stars	$2.96 -3.9%	$8.50 +187.2%	-38.6%	$315.94M	$173.61M	7.59	N/A
LFMD LifeMD	2.8977 of 5 stars	$4.88 -0.6%	$9.14 +87.4%	-57.7%	$237.46M	$194.05M	97.62	230

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNR) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Burning Rock Biotech (BNR) Competitors

BNR vs. AUNA, AIRS, SBC, LFMD, and BDSX

How does Burning Rock Biotech compare to Auna?

Summary

How does Burning Rock Biotech compare to AirSculpt Technologies?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Summary

How does Burning Rock Biotech compare to LifeMD?

Summary

How does Burning Rock Biotech compare to Biodesix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Burning Rock Biotech (BNR) Competitors

BNR vs. AUNA, AIRS, SBC, LFMD, and BDSX

How does Burning Rock Biotech compare to Auna?

Do analysts recommend BNR or AUNA?

Is BNR or AUNA more profitable?

Does the media prefer BNR or AUNA?

Which has higher valuation & earnings, BNR or AUNA?

Do insiders & institutionals believe in BNR or AUNA?

Which has more volatility and risk, BNR or AUNA?

Summary

How does Burning Rock Biotech compare to AirSculpt Technologies?

Do insiders and institutionals have more ownership in BNR or AIRS?

Which has more volatility and risk, BNR or AIRS?

Which has preferable earnings and valuation, BNR or AIRS?

Is BNR or AIRS more profitable?

Does the media favor BNR or AIRS?

Do analysts recommend BNR or AIRS?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Which has preferable earnings & valuation, BNR or SBC?

Is BNR or SBC more profitable?

Do institutionals & insiders hold more shares of BNR or SBC?

Do analysts recommend BNR or SBC?

Which has more volatility & risk, BNR or SBC?

Does the media favor BNR or SBC?

Summary

How does Burning Rock Biotech compare to LifeMD?

Is BNR or LFMD more profitable?

Do insiders & institutionals believe in BNR or LFMD?

Which has preferable valuation and earnings, BNR or LFMD?

Does the media refer more to BNR or LFMD?

Do analysts prefer BNR or LFMD?

Which has more volatility & risk, BNR or LFMD?

Summary

How does Burning Rock Biotech compare to Biodesix?

Does the media prefer BNR or BDSX?

Do insiders & institutionals believe in BNR or BDSX?

Do analysts rate BNR or BDSX?

Is BNR or BDSX more profitable?

Which has higher valuation & earnings, BNR or BDSX?

Which has more volatility & risk, BNR or BDSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools